CIM
CME icon

Contravisory Investment Management’s CME Group CME Stock Holding History

Contravisory Investment Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,741
Closed -$375K – 356
2024
Q1 		$375K Buy
1,741
+44
+3% +$9.24K 0.08% 161
2023
Q4 		$357K Buy
+1,697
New +$362K 0.09% 161
2020
Q3 		– Sell
-1,232
Closed -$217K – 257
2020
Q2 		$217K Buy
1,232
+397
+48% +$71.2K 0.08% 142
2020
Q1 		$144K Buy
835
+374
+81% +$74.4K 0.06% 150
2019
Q4 		$93K Buy
461
+77
+20% +$15.8K 0.03% 191
2019
Q3 		$81K Buy
384
+40
+12% +$8.36K 0.03% 188
2019
Q2 		$67K Buy
344
+64
+23% +$11.8K 0.03% 202
2019
Q1 		$46K Buy
280
+27
+11% +$4.77K 0.02% 229
2018
Q4 		$48K Buy
253
+168
+198% +$31K 0.02% 203
2018
Q3 		$14K Buy
+85
New +$14.3K 0.01% 229
2016
Q3 		– Sell
-22
Closed -$2K – 291
2016
Q2 		$2K Buy
+22
New +$2.08K ﹤0.01% 160

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Contravisory Investment Management's CME Position: Q2 2024 in Review

Contravisory Investment Management sold out of CME Group (CME) in Q2 2024, closing a stake of 1,741 shares — an estimated $375K sold.

Contravisory Investment Management first reported a position in CME in Q2 2016 and held it in 11 quarters. The position peaked at $375K in Q1 2024. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.

  • Contravisory Investment Management reported no remaining CME Group position as of Q2 2024 after selling out during the quarter.
  • Contravisory Investment Management sold 1,741 CME Group shares in Q2 2024, an estimated $375K.
  • Contravisory Investment Management first reported a position in CME Group in Q2 2016 and held it in 11 quarters.
  • Contravisory Investment Management's CME Group position peaked at $375K in Q1 2024.
  • 1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.

Based on Contravisory Investment Management's 13F filing for Q2 2024, filed 10 Jul 2024.